Cargando…

Current Status and Future Perspectives of Androgen Receptor Inhibition Therapy for Prostate Cancer: A Comprehensive Review

The androgen receptor (AR) is one of the main components in the development and progression of prostate cancer (PCa), and treatment strategies are mostly directed toward manipulation of the AR pathway. In the metastatic setting, androgen deprivation therapy (ADT) is the foundation of treatment in pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Tae Jin, Lee, Young Hwa, Koo, Kyo Chul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064397/ https://www.ncbi.nlm.nih.gov/pubmed/33805919 http://dx.doi.org/10.3390/biom11040492

Ejemplares similares

Current Status and Future Perspectives of Checkpoint Inhibitor Immunotherapy for Prostate Cancer: A Comprehensive Review
por: Kim, Tae Jin, et al.
Publicado: (2020)

Current and future perspectives on CAR-T cell therapy for renal cell carcinoma: A comprehensive review
por: Kim, Tae Jin, et al.
Publicado: (2022)

Current Status and Application of Metformin for Prostate Cancer: A Comprehensive Review
por: Ahn, Hyun Kyu, et al.
Publicado: (2020)

Current Status and Future Perspectives of Immunotherapy for Locally Advanced or Metastatic Urothelial Carcinoma: A Comprehensive Review
por: Kim, Tae Jin, et al.
Publicado: (2020)

Pathophysiology of Bone Loss in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy and Lifestyle Modifications for the Management of Bone Health: A Comprehensive Review
por: Kim, Tae Jin, et al.
Publicado: (2020)

Comprehensive analysis of androgen receptor status in prostate cancer with neuroendocrine differentiation
por: Su, Ruopeng, et al.
Publicado: (2022)

Current perspectives on FOXA1 regulation of androgen receptor signaling and prostate cancer
por: Yang, Yeqing Angela, et al.
Publicado: (2015)

Survival Outcomes of Concurrent Treatment with Docetaxel and Androgen Deprivation Therapy in Metastatic Castration-Resistant Prostate Cancer
por: Jang, Ho Seong, et al.
Publicado: (2016)

Treatment of Oligometastatic Hormone-Sensitive Prostate Cancer: A Comprehensive Review
por: Koo, Kyo Chul, et al.
Publicado: (2018)

Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate Cancer
por: Denmeade, Samuel R, et al.
Publicado: (2023)

The Current Status and Future Perspectives of Chimeric Antigen Receptor-Engineered T Cell Therapy for the Management of Patients with Endometrial Cancer
por: Choi, Ji-Young, et al.
Publicado: (2023)

Current Status and Future Perspectives in Differentiated Thyroid Cancer
por: Kim, Tae Yong, et al.
Publicado: (2014)

Selective androgen receptor modulators: the future of androgen therapy?
por: Christiansen, Andrew R., et al.
Publicado: (2020)

Current Status and Future Perspectives on Stem Cell-Based Therapies for Parkinson’s Disease
por: Cha, Young, et al.
Publicado: (2023)

Effect of Prior Local Treatment and Prostate-Specific Antigen Kinetics during Androgen-Deprivation Therapy on the Survival of Castration-Resistant Prostate Cancer
por: Hah, Yoon Soo, et al.
Publicado: (2019)

Unrecognized Kinetics of Serum Testosterone: Impact on Short-Term Androgen Deprivation Therapy for Prostate Cancer
por: Koo, Kyo Chul, et al.
Publicado: (2014)

Comprehensive Genomic Profiling of Androgen-Receptor-Negative Canine Prostate Cancer
por: Laufer-Amorim, Renée, et al.
Publicado: (2019)

Anti-Androgen Receptor Therapies in Prostate Cancer: A Brief Update and Perspective
por: Huang, Jian, et al.
Publicado: (2022)

Optimal PSA Threshold for Androgen-Deprivation Therapy in Patients with Prostate Cancer following Radical Prostatectomy and Adjuvant Radiation Therapy
por: Ahn, Hyun Kyu, et al.
Publicado: (2020)

Androgen Receptor Signaling Inhibition in Advanced Castration Resistance Prostate Cancer: What Is Expected for the Near Future?
por: Pozas, Javier, et al.
Publicado: (2022)

Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
por: Chuu, Chih-Pin, et al.
Publicado: (2011)

Zinc Inhibits Expression of Androgen Receptor to Suppress Growth of Prostate Cancer Cells
por: To, Phuong Kim, et al.
Publicado: (2018)

Endoscopic Bariatric Therapies: Current Status and Future Perspectives
por: Ibrahim Mohamed, Baraa Kamal, et al.
Publicado: (2022)

PET imaging of urokinase-type plasminogen activator receptor (uPAR) in prostate cancer: current status and future perspectives
por: Skovgaard, Dorthe, et al.
Publicado: (2016)

Lutetium-177 Labelled PSMA Targeted Therapy in Advanced Prostate Cancer: Current Status and Future Perspectives
por: Seitzer, Konstantin Egon, et al.
Publicado: (2021)

Androgen receptor-mediated upregulation of quaking affects androgen receptor-related prostate cancer development and anti-androgen receptor therapy
por: Zhang, Keke, et al.
Publicado: (2018)

Shikonin inhibits the growth of human prostate cancer cells via modulation of the androgen receptor
por: JANG, SOON YOUNG, et al.
Publicado: (2014)

Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in Asia
por: Kitagawa, Yasuhide, et al.
Publicado: (2015)

Targeting the androgen receptor in triple-negative breast cancer: current perspectives
por: Mina, Alain, et al.
Publicado: (2017)

Alternative Methods for Testing Botulinum Toxin: Current Status and Future Perspectives
por: Nepal, Mahesh Raj, et al.
Publicado: (2020)

Dominant-Negative Androgen Receptor Inhibition of Intracrine Androgen-Dependent Growth of Castration-Recurrent Prostate Cancer
por: Titus, Mark A., et al.
Publicado: (2012)

Biological and Clinical Significance of Androgens and Androgen Receptor in Prostate Cancer
por: Koochekpour, Shahriar
Publicado: (2014)

Boron neutron capture therapy: Current status and future perspectives
por: Dymova, Mayya Alexandrovna, et al.
Publicado: (2020)

Incretin-based therapies in 2021 – Current status and perspectives for the future
por: Rizzo, Manfredi, et al.
Publicado: (2021)

Current status and future perspectives on neoadjuvant therapy in gastric cancer
por: Ao, Sheng, et al.
Publicado: (2021)

Gene Therapy for Mitochondrial Diseases: Current Status and Future Perspective
por: Di Donfrancesco, Alessia, et al.
Publicado: (2022)

Bispecific Antibodies in Prostate Cancer Therapy: Current Status and Perspectives
por: Heitmann, Jonas S., et al.
Publicado: (2021)

RICH upgrade: Current status and future perspectives
por: Pistone, A
Publicado: (2016)

Congenital hyperinsulinism: current status and future perspectives
por: Yorifuji, Tohru
Publicado: (2014)

Lipid nanoceuticals: Current status and future perspective
por: Narang, Jasjeet Kaur
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_klamanehvu3q07tdie3geachp1